MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

Search

Thermo Fisher Scientific Inc

Cerrado

SectorSalud

489.21 1.42

Resumen

Variación precio

24h

Actual

Mínimo

480.45

Máximo

491.12

Métricas clave

By Trading Economics

Ingresos

194M

1.8B

Ventas

795M

11B

P/B

Media del Sector

30.121

63.778

BPA

6.1

Rentabilidad por dividendo

0.35

Margen de beneficio

16.007

Empleados

125,000

EBITDA

377M

3B

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 meses

+38.06% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

0.35%

2.39%

Próximas Ganancias

23 abr 2025

Fecha Próximo Dividendo

15 abr 2025

Próxima Fecha de Ex Dividendo

13 jun 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

-40B

189B

Apertura anterior

487.79

Cierre anterior

489.21

Noticias sobre sentimiento de mercado

By Acuity

33%

67%

106 / 386 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Strong Bearish Evidence

Thermo Fisher Scientific Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

25 feb 2025, 14:05 UTC

Adquisiciones, fusiones, absorciones

Thermo Fisher Scientific to Acquire Solventum's Filtration Unit, Confirming WSJ Report

30 ene 2025, 11:43 UTC

Ganancias

Thermo Fisher Scientific Profit, Revenue Rose in 4Q

23 oct 2024, 10:43 UTC

Ganancias

Thermo Fisher Raises Floor of Earnings Target After Steady 3Q Sales

25 feb 2025, 14:09 UTC

Adquisiciones, fusiones, absorciones

Thermo Fisher Strikes Deal for Solventum's Filtration Unit -- WSJ

25 feb 2025, 13:41 UTC

Adquisiciones, fusiones, absorciones

Solventum: Transaction Is Expected to Be Completed by End of 2025 >SOLV

25 feb 2025, 13:40 UTC

Adquisiciones, fusiones, absorciones

Solventum Expects Estimated $3.4 B in Net Proceeds >SOLV

25 feb 2025, 13:40 UTC

Adquisiciones, fusiones, absorciones

Solventum: Deal Strengthens Balance Sheet With Proceeds to Be Used Primarily for Debt Paydown >SOLV

25 feb 2025, 13:40 UTC

Adquisiciones, fusiones, absorciones

Solventum Expects Deal to Be Neutral to 2025 EPS >SOLV

25 feb 2025, 13:40 UTC

Adquisiciones, fusiones, absorciones

Solventum: Deal Accelerates Business Transformation and Sharpens Focus on Strategic Areas for Growth

25 feb 2025, 13:39 UTC

Adquisiciones, fusiones, absorciones

Solventum Announces Sale of Its Purification & Filtration Business to Thermo Fisher Scientific Inc. for $4.1B

25 feb 2025, 13:33 UTC

Adquisiciones, fusiones, absorciones

Thermo Fisher: Solventum Business Generated About $1 Billion Revenue in 2024 >TMO

25 feb 2025, 13:32 UTC

Adquisiciones, fusiones, absorciones

Thermo Fisher to Buy Solventum Purification, Filtration Business for About $4.1 Billion Cash >TMO SOLV

25 feb 2025, 13:32 UTC

Adquisiciones, fusiones, absorciones

Thermo Fisher Scientific To Acquire Solventum's Purification And Filtration Business >TMO

24 feb 2025, 23:03 UTC

Adquisiciones, fusiones, absorciones

Thermo Fisher Scientific Nears Deal for Solventum's Purification and Filtration Business, Sources Say -- WSJ

24 feb 2025, 23:03 UTC

Principales Noticias
Adquisiciones, fusiones, absorciones

Thermo Fisher Nears Deal for Solventum Filtration Unit -- WSJ

24 feb 2025, 23:03 UTC

Adquisiciones, fusiones, absorciones

Deal Could be Announced This Week, Sources Say -- WSJ

24 feb 2025, 23:03 UTC

Adquisiciones, fusiones, absorciones

Transaction Could Value Solventum Filtration Business Between $3.5B to $4B, Sources Say -- WSJ

30 ene 2025, 11:06 UTC

Ganancias

Thermo Fisher: In a Great Position to Deliver Excellent Performance in 2025 >TMO

30 ene 2025, 11:05 UTC

Ganancias

Thermo Fisher: Will Provide 2025 Fincl Guidance During Earnings Conference Call Thursday Morning >TMO

30 ene 2025, 11:00 UTC

Ganancias

Thermo Fisher 4Q Rev $11.4B >TMO

30 ene 2025, 11:00 UTC

Ganancias

Thermo Fisher 4Q EPS $4.78 >TMO

30 ene 2025, 11:00 UTC

Ganancias

Thermo Fisher 4Q Core Organic Revenue Up 5% >TMO

30 ene 2025, 11:00 UTC

Ganancias

Thermo Fisher 4Q Net $1.83B >TMO

30 ene 2025, 11:00 UTC

Ganancias

Thermo Fisher 4Q Adj EPS $6.10 >TMO

16 dic 2024, 22:03 UTC

Principales Noticias

Novo's New Deal May End Wegovy Shortages. It Could Reshape the Pharma Industry Along the Way. -- Barrons.com

23 oct 2024, 10:02 UTC

Ganancias

Thermo Fisher Had Seen 2024 Adjusted EPS $21.29-$22.07 >TMO

23 oct 2024, 10:02 UTC

Ganancias

Thermo Fisher Backs 2024 View of Rev $42.4B-$43.3B >TMO

23 oct 2024, 10:00 UTC

Ganancias

Thermo Fisher 3Q Core Organic Revenue 0% >TMO

23 oct 2024, 10:00 UTC

Ganancias

Thermo Fisher 3Q EPS $4.25 >TMO

23 oct 2024, 10:00 UTC

Ganancias

Thermo Fisher 3Q Adj EPS $5.28 >TMO

Comparación entre iguales

Cambio de precio

Thermo Fisher Scientific Inc Esperado

Precio Objetivo

By TipRanks

38.06% repunte

Estimación a 12 meses

Media 666.81 USD  38.06%

Máximo 715 USD

Mínimo 570 USD

De acuerdo con 17 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Thermo Fisher Scientific Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

17 ratings

14

Comprar

3

Mantener

0

Vender

Puntuación técnica

By Trading Central

N/A / 513.14Soporte y Resistencia

Corto Plazo

Strong Bearish Evidence

Medio plazo

Weak Bearish Evidence

Largo Plazo

Bearish Evidence

Sentimiento

By Acuity

106 / 386 Clasificación en Salud

Noticias sobre sentimiento de mercado

Coyuntura alcista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por encima de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Thermo Fisher Scientific Inc

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. It has a collaboration agreement with Mainz Biomed N.V. for the development of colorectal cancer screening product. Thermo Fisher Scientific Inc. was founded in 1956 and is headquar